Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 December 1983:
Vol. 222. no. 4628, pp. 1129 - 1132
DOI: 10.1126/science.6648524
Prev | Table of Contents | Next

Articles

Science, Vol 222, Issue 4628, 1129-1132
Copyright © 1983 by American Association for the Advancement of Science

articles

Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen

KY Hui, E Haber, and GR Matsueda

A synthetic heptapeptide from the amino terminus of the beta chain in human fibrin was used as an antigen to produce monoclonal antibodies that bind to fibrin even in the presence of human fibrinogen at the concentration found in plasma. As expected, the antifibrin activity was inhibited by the peptide antigen but not by a control heptapeptide. In a chicken ex vivo circulatory model for fibrin detection, intravenously administered monoclonal antibodies bound to human fibrin-coated disks placed in an extracorporeal chamber. These findings may lead to better methods for identifying deep vein and coronary artery thrombi.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection.
J. J. T. H. Roelofs, K. M. A. Rouschop, G. J. D. Teske, G. T. M. Wagenaar, N. Claessen, J. J. Weening, T. van der Poll, and S. Florquin (2009)
Nephrol. Dial. Transplant. 24, 801-808
   Abstract »    Full Text »    PDF »
Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots.
M. Neyman, J. Gewirtz, and M. Poncz (2008)
Blood 112, 1101-1108
   Abstract »    Full Text »    PDF »
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury.
Y. P. de Visser, F. J. Walther, E. H. Laghmani, S. van Wijngaarden, K. Nieuwland, and G. T. M. Wagenaar (2008)
Eur. Respir. J. 31, 633-644
   Abstract »    Full Text »    PDF »
Inhaled nitric oxide attenuates pulmonary inflammation and fibrin deposition and prolongs survival in neonatal hyperoxic lung injury.
S. A. J. ter Horst, F. J. Walther, B. J. H. M. Poorthuis, P. S. Hiemstra, and G. T. M. Wagenaar (2007)
Am J Physiol Lung Cell Mol Physiol 293, L35-L44
   Abstract »    Full Text »    PDF »
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
C. Kleinschnitz, G. Stoll, M. Bendszus, K. Schuh, H.-U. Pauer, P. Burfeind, C. Renne, D. Gailani, B. Nieswandt, and T. Renne (2006)
J. Exp. Med. 203, 513-518
   Abstract »    Full Text »    PDF »
Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury.
S. A. J. ter Horst, G. T. M. Wagenaar, E. de Boer, M. A. van Gastelen, J. C. M. Meijers, B. J. Biemond, B. J. H. M. Poorthuis, and F. J. Walther (2004)
J Appl Physiol 97, 2014-2019
   Abstract »    Full Text »    PDF »
Myocardial fibrosis in mice with overexpression of human blood coagulation factor IX.
A. Ameri, S. Kurachi, K. Sueishi, M. Kuwahara, and K. Kurachi (2003)
Blood 101, 1871-1873
   Abstract »    Full Text »    PDF »
Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation.
J. H. Erlich, E. M. Boyle, J. Labriola, J. C. Kovacich, R. A. Santucci, C. Fearns, E. N. Morgan, W. Yun, T. Luther, O. Kojikawa, et al. (2000)
Am. J. Pathol. 157, 1849-1862
   Abstract »    Full Text »    PDF »
Monoclonal Antibody Designated T2G1 Reacts With Human Fibrin {beta}-Chain but Not With the Corresponding Chain From Mouse Fibrin.
B. J. Kudryk, A. Bini, S. R. Kumar, and B. V. Zlokovic (2000)
Arterioscler. Thromb. Vasc. Biol. 20, 1848-1849
   Full Text »    PDF »
Construction and Functional Evaluation of a Single-Chain Antibody Fusion Protein With Fibrin Targeting and Thrombin Inhibition After Activation by Factor Xa.
K. Peter, J. Graeber, S. Kipriyanov, M. Zewe-Welschof, M. S. Runge, W. Kubler, M. Little, and C. Bode (2000)
Circulation 101, 1158-1164
   Abstract »    Full Text »    PDF »
Immunoscintigraphy of Venous Thrombi: Clinical Effectiveness of a New Antifibrin D-Dimer Monoclonal Antibody.
M. Ciavolella, R. Tavolaro, M. Di Loreto, F. La Torre, A. Nicolai, O. Schillaci, M. Ierardi, F. Scopinaro, and M. Ciavolella (1999)
Angiology 50, 103-109
   Abstract »    PDF »
Inhibition of Metastases by Anticoagulants.
M. Hejna, M. Raderer, and C. C. Zielinski (1999)
J Natl Cancer Inst 91, 22-36
   Abstract »    Full Text »    PDF »
Antipeptide Monoclonal Antibodies to Defined Fibrinogen Aalpha Chain Regions: Anti-Aalpha 487-498, a Structural Probe for Fibrinogenolysis.
J. H. Sobel, I. Trakht, N. Pileggi, and H. Qi Wu (1998)
Blood 91, 1590-1598
   Abstract »    Full Text »    PDF »
Antibodies Against the Fibrin ß-Chain Amino-Terminus Detect Active Canine Venous Thrombi.
T. A. Morris, J. J. Marsh, R. Konopka, C. A. Pedersen, P. G. Chiles, R. Fagnani, M. Hagan, and K. M. Moser (1997)
Circulation 96, 3173-3179
   Abstract »    Full Text »
Tissue Factor Expression on Macrophages in Coronary Plaques in Patients with Unstable Angina.
K. Kaikita, H. Ogawa, H. Yasue, M. Takeya, K. Takahashi, T. Saito, K. Hayasaki, K. Horiuchi, A. Takizawa, Y. Kamikubo, et al. (1997)
Arterioscler. Thromb. Vasc. Biol. 17, 2232-2237
   Abstract »    Full Text »
Antithrombotic Potency of Hirudin Is Increased in Nonhuman Primates by Fibrin Targeting.
C. Bode, S. R. Hanson, J. F. Schmedtje, E. Haber, P. Mehwald, A. B. Kelly, L. A. Harker, and M. S. Runge (1997)
Circulation 95, 800-804
   Abstract »    Full Text »
Immunoscintigraphic Detection of Venous Thrombosis of the Lower Extremities by Means of Human Antifibrin Monoclonal Antibodies Labeled with 111In.
L. Lusiani, P. Zanco, A. Visona, G. Breggion, A. Pagnan, and G. Ferlin (1989)
Angiology 40, 671-677
   Abstract »    PDF »
Innovative approaches to plasminogen activator therapy.
E Haber, T Quertermous, G. Matsueda, and M. Runge (1989)
Science 243, 51-56
   Abstract »    PDF »
Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes.
K. Bloch, J. Scott, J. Zisfein, J. Fallon, M. Margolies, C. Seidman, G. Matsueda, C. Homcy, R. Graham, and J. Seidman (1985)
Science 230, 1168-1171
   Abstract »    PDF »
Antibody-directed urokinase: a specific fibrinolytic agent.
C Bode, G. Matsueda, K. Hui, and E Haber (1985)
Science 229, 765-767
   Abstract »    PDF »
Potentiation of Endogenous Fibrinolysis and Rescue from Lung Ischemia/Reperfusion Injury in Interleukin (IL)-10-reconstituted IL-10 Null Mice.
K. Okada, T. Fujita, K. Minamoto, H. Liao, Y. Naka, and D. J. Pinsky (2000)
J. Biol. Chem. 275, 21468-21476
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)